Lewis William's Form 4 filing
INSMED Inc (INSM) · filed Aug 6, 2025
- Accession no.
- 0001402051-25-000004
- Filed
- Aug 6, 2025
- Trade date
- Aug 4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $750.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis WilliamCIK 0001402051 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | Common Stock | MOption exerciseAcquired | +6,830 | $10.85 | +$74,105.5 | 240,754 | Indirect | |
| Aug 4, 2025 | Common Stock | SSaleDisposed | −1,693 | $108.80F2 | −$184,198.4 | 239,061 | Indirect | |
| Aug 4, 2025 | Common Stock | SSaleDisposed | −3,199 | $109.68F3 | −$350,866.32 | 235,862 | Indirect | |
| Aug 4, 2025 | Common Stock | SSaleDisposed | −1,938 | $110.91F4 | −$214,943.58 | 233,924 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | Common Stock | MOption exerciseDisposed | −6,830 | $0.00 | $0 | 6,865 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 1,693 shares sold at prices ranging from $108.24 to $109.23 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 3,199 shares sold at prices ranging from $109.25 to $110.23 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 1,938 shares sold at prices ranging from $110.26 to $111.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.